OneSkin

About:

OneSkin is a longevity company developing products designed to extend skin and body health by targeting aging at its source.

Website: https://www.oneskin.co/

Twitter/X: oneskintech

Top Investors: IndieBio, Metaplanet, SOSV, Able Partners, Selva Ventures

Description:

OneSkin is a longevity company on a mission to extend the health of your skin and body. Founded by a team of four PhDs and longevity scientists, they have identified a novel proprietary peptide, OS-01, which is the first compound validated to reduce your skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity and strengthening the epidermal skin barrier. Their flagship product, OS-01 Topical Supplement is currently available through their website.

Total Funding Amount:

$26.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

information(AT)oneskintech.com

Founders:

Alessandra Zonari, Andres Ochoa Cruz, Carolina Reis Oliveira, Juliana Carvalho

Number of Employees:

11-50

Last Funding Date:

2024-11-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai